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ORIGINAL ARTICLE
Cigarette smoking and thinning of the brain’s cortex
S Karama1,2, S Ducharme1,3,4,5, J Corley6, F Chouinard-Decorte1, JM Starr7,8, JM Wardlaw7,9,10, ME Bastin7,9,10 and IJ Deary6,7
Cigarette smoking is associated with cognitive decline and dementia, but the extent of the association between smoking and
structural brain changes remains unclear. Importantly, it is unknown whether smoking-related brain changes are reversible
after smoking cessation. We analyzed data on 504 subjects with recall of lifetime smoking data and a structural brain magnetic
resonance imaging at age 73 years from which measures of cortical thickness were extracted. Multiple regression analyses were
performed controlling for gender and exact age at scanning. To determine dose–response relationships, the association between
smoking pack-years and cortical thickness was tested and then repeated, while controlling for a comprehensive list of covariates
including, among others, cognitive ability before starting smoking. Further, we tested associations between cortical thickness
and number of years since last cigarette, while controlling for lifetime smoking. There was a diffuse dose-dependent negative
association between smoking and cortical thickness. Some negative dose-dependent cortical associations persisted after
controlling for all covariates. Accounting for total amount of lifetime smoking, the cortex of subjects who stopped smoking
seems to have partially recovered for each year without smoking. However, it took ~ 25 years for complete cortical recovery in
affected areas for those at the mean pack-years value in this sample. As the cortex thins with normal aging, our data suggest that
smoking is associated with diffuse accelerated cortical thinning, a biomarker of cognitive decline in adults. Although partial
recovery appears possible, it can be a long process.
Molecular Psychiatry advance online publication, 10 February 2015; doi:10.1038/mp.2014.187
INTRODUCTION
Cigarette smoking has well-documented associations with
numerous negative health outcomes including possible effects
on the brain.1 Evidence suggests that smokers have, on average,
slightly poorer global cognitive functioning in later life, as well
as lower mean scores on several cognitive domains such as
cognitive ﬂexibility and memory.2 Longitudinal studies and
meta-analyses report that smoking is associated with an increased
risk of dementia3 and it is estimated that nearly 14% of
Alzheimer’s disease cases worldwide could be attributable to
smoking.3
In keeping with this, cigarette smoking has been linked to
regional brain atrophy and reduced cortical volume in a few
cortical regions.4–10 Recently, two studies reported associations
between smoking and the brain’s cortex, using cortical thickness,
a metric viewed as a proxy marker of cortical cytoarchitecture
integrity and considered to be more sensitive to neurodegenera-
tive processes than cortical volume.11 Kuhn et al.,12 comparing 22
smokers with 21 controls, and Durazzo et al.,11 comparing 43
smokers with 33 non-smokers with alcohol dependence, reported
smoking-related cortical thinning in a few isolated cortical regions.
However, larger samples may be required to detect local cortical
thickness effects13 in whole-brain analyses, raising the possibility
of type 2 statistical error in these studies.
Crucially, it is not known whether some of the possible effects
of smoking on the brain are reversible. This is important given the
unprecedented degree of aging of the world’s human population,
the fact that many people continue to smoke into old age2 and
the possibility that stopping early enough may help toward
delaying dementia if it leads to a reversal of cortical thinning
effects of smoking.
Here we examine the association between smoking and brain
cortical thickness in the Lothian Birth Cohort 1936 (LBC1936).14 This
group of community-dwelling individuals has undergone brain
magnetic resonance imaging (MRI) at ~73 years of age and
provided data on lifetime history of smoking, a valid measure of
tobacco use.15 Many potential confounding variables are available
on this cohort including a measure of cognitive ability at 11 years of
age (that is, before beginning smoking). This is useful given
previously reported positive associations between cognitive ability
across the life course and cortical thickness in old age,16 negative
associations between cognitive ability and likelihood of smoking,
and positive associations between cognitive ability and probability
of quitting smoking.2 Although one of the goals here was to reassess
the extent of smoking-related cortical thinning by capitalizing on the
increased power provided by the large brain imaging LBC1936
cohort, an important aim was to evaluate the degree of potential
reversibility of smoking-related cortical thinning. In light of accruing
evidence of brain plasticity in adults17 and the observed reversal of
risk for some health outcomes after smoking cessation,18 we
predicted at least a partial reversal of smoking-related cortical
thinning in those who had stopped smoking.
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As members of the LBC1936, most participants had taken part in the
Scottish Mental Survey of 1947 in which almost all Scottish school children
born in 1936 and attending school in June 1947 were cognitively tested. In
2007, during the second Wave of the LBC1936 study, 866 surviving
members from the Edinburgh area, who were able and willing to undergo
a set of cognitive and medical tests,14 were invited to have brain MRI
scans.19 From these, 666 underwent brain imaging including high-
resolution structural T1-weighted MRI scanning used for cortical thickness
estimation (see MRI acquisition section for scanning details).
From the 666 subjects with brain MRI data, 504 (260 females) had the
relevant smoking and confounding variable data available, and had no
evidence of dementia (as assessed by self-report during medical history
taking and by excluding subjects with a Mini Mental State Examination20
score below 24 (refs. 21,22)). There were 36 current smokers, 223 ex-
smokers and 245 participants with no history of smoking. Their mean age
(± s.d.) was 72.7 years ( ±8.9 months). Their mean pack-years was 29.7 and
ranged from 0.08 to 164. For further details on data availability and
attrition, see Figure 1 and section 1 of Supplementary Information).
Data collection details
All subjects were interviewed and tested individually by a trained
psychologist and a research nurse during a visit to the Wellcome Trust
Clinical Research Facility (http://www.wtcrf.ed.ac.uk), Western General
Hospital, Edinburgh. This visit included cognitive and other psychological
assessments, physical examinations, extensive history taking and blood
analyses14 (see Table 1 for sample characteristics).
Disease history was obtained as part of a structured interview. Data were
collected on current and past cigarette, cigar and pipe smoking. Detailed
information was obtained regarding age at which subjects started to
smoke, age at cessation for ex-smokers and average number of cigarettes
smoked per day. Pack-years of smoking was calculated as the average
number of cigarettes per day multiplied by years as a smoker, divided by
20 (cigarettes per pack). Data on typical, recent alcohol consumption were
collected by asking about type, amount and frequency of alcoholic drinks.
The HADS scale (Hospital Anxiety and Depression Scale)23 was adminis-
tered to assess recent mood states.
Adult occupational social class, as determined from Her Majesty’s
Stationery Ofﬁce Classiﬁcation of Occupations,24 was used to estimate
socioeconomic status (SES). This was derived from each participant’s
highest reported occupation and classiﬁed into one of six categories
ranging from I (professional occupations) to V (unskilled occupations), with
III divided into IIIN (non-manual) and IIIM (manual).
Blood analyses were used to obtain lipid proﬁles and hemoglobin A1c
levels. Spirometry was used to calculate FEV1. During the physical
examination, three measures of sitting diastolic and systolic blood pressure
were made.
Cognitive ability was measured in June 1947 (at ~ 11 years of age), using
the Moray House Test No. 12. The Moray House Test cognitive ability scores
have high concurrent validity with gold-standard scales of intelligence
such as the Stanford–Binet in childhood25 and the Wechsler Scale of
Intelligence-III in old age.26
MRI acquisition
Participants were scanned on average 2.1 months (s.d. ± 1.2 months) after
the cognitive and medical testing. MRI scans were performed using a GE
Signa Horizon HDxt 1.5 T clinical scanner (General Electric, Milwaukee, WI,
USA). The protocol included T1-, T2-, T2*-weighted and FLAIR whole-brain
scans. For the T1-weighted scans, high-resolution whole-brain T1-weighted
volume scans were acquired with a ﬁeld of view of 256× 256 mm2,
an acquisition matrix of 192× 192 (zero-ﬁlled to 256× 256) and 160
contiguous 1.3-mm-thick slices yielding ﬁnal voxel dimensions of
1 × 1× 1.3 mm3. For further details regarding the T1-weighted MRI
acquisition protocol, see section 2 of Supplementary Information. For T2-,
T2*-weighted and FLAIR sequence details, see Wardlaw et al.
19
MRI processing
To determine local cortical thickness measurements for each subject, the
T1-weighted volume scans were processed using the automated CIVET
pipeline (version 1.1.12) developed at the Montreal Neurological Institute
(http://www.bic.mni.mcgill.ca). For details regarding CIVET processing
steps, see section 3 of Supplementary Information.
In order to be able to account for the potential impacts of subclinical
cerebrovascular disease, we used FLAIR images (checking T1- and
T2-weighted images when necessary) to obtain each subject’s Fazekas
score, a standardized visual rating scale that provides a measure of white
matter hyperintensities (WMH) load.27 Speciﬁcally, Fazekas scores were
assessed by one of two experienced ‘board certiﬁed’ neuroradiologists as
Figure 1. Flowchart depicting the step-by-step selection process of
the Lothian Birth Cohort 1936 (LBC1936) subjects included in the
ﬁnal sample for data analyses. MRI, magnetic resonance imaging; IQ,
intellectual quotient; FEV1, forced expiratory volume in 1 s; MMSE,
mini-mental status examination; QC, quality control.
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periventricular (0–3) and deep (0–3) WMH scores and then summed to get
a total score out of 6.
Statistical analyses
Statistical analyses were performed using SurfStat (www.math.mcgill.ca/
keith/surfstat) for local cortical thickness analyses and with SPSS 20 (SPSS,
Chicago, IL, USA) for all other analyses. All analyses were conducted while
accounting for the effects of gender and exact age at scanning in days, in
order to account for any remaining residual age effect. For local cortical
thickness analyses, a t-value was calculated for the slope of the β-coefﬁcient
(estimated from the regression model) of the variable of interest (for
example, pack-years or number of years since last cigarette depending on
the analysis) at each cortical point, thereby producing a three-dimensional
t-statistic map. A t-value threshold of statistical signiﬁcance was established
taking into account multiple comparisons via the false discovery rate (FDR).
For all local cortical thickness analyses, an FDR threshold of 0.05 was used to
account for multiple comparisons across the cortex. However, for Model 3, a
more lenient exploratory FDR=0.20 threshold was also used to further
examine the data (for an FDR=0.2 threshold, the expectation is that 80% of
ﬁndings are true positives). The rationale for complementing the original
FDR= 0.05 results with results from this more lenient exploratory threshold
is that the large number of covariates used in Model 3 may lead to false
negatives via decreased sensitivity of the model due to a loss in degrees of
freedom. Further, given the known strong links between cigarette smoking
and FEV1,28 as well as with cerebrovascular disease,1 covarying for FEV1 and
Fazekas score might substantially control for the amount of smoking and
hence overcontrol for the effect of interest, namely the possible impact of
smoking on the cortex.
In order to provide information regarding effect size, ranges of
correlation values derived from the three-dimensional t-statistic maps
(using r= t /√(df+t2) were also calculated.
Model 1. As a ﬁrst step, the following general linear model was used to
test the association between smoking status category (that is, smokers, ex-




Model 2. Next, in order to more effectively assess the dose–response
relationship between smoking and cortical thickness, the Smoking-Category
term was replaced by a Pack-Years term. This analysis, as well as those of
Models 3 and 4 below, were restricted to current and ex-smokers (n=259):
Cortical thickness =b0Intercept+b1Gender+b2Exact_Age_At_Scanning
+b3PackYears+error
Model 3. The dose–response association was then re-examined while
controlling for potential mediating and confounding variables. These
covariates included HDL (high-density lipoprotein) cholesterol, LDL (low-
density lipoprotein) cholesterol, HDL cholesterol ratio, triglycerides, sitting
diastolic and systolic blood pressure (mean of three measures), history of
high blood pressure, history of stroke or cardiovascular disease, Fazekas
score, FEV1, alcohol units per week, hemoglobin A1c, diagnosis of diabetes,




Table 1. Detailed demographic variables and covariates divided by smoking categories
Never smoked n= 245 Ex-smokers n= 223 Current smokers n= 36
Age at MRI (years) 72.7± 0.7 (71.2–74.2) 72.7± 0.8 (71.0–74.2) 72.7± 0.6 (71.6–73.9)
Gender Female= 136 (55.5) Female= 104 (46.6) Female= 20 (55.6)
Male= 109 (44.4) Male= 119 (53.4) Male= 16 (44.4)
IQ at age 11 years 101.6± 15.2 (38.5–128.0) 101.8± 14.3 (62.1–129.9) 99.8± 10.7 (78.3–119.6)
Socioeconomic status I= 58 (23.7) I= 47 (21.1) I= 3 (8.3)
II= 90 (36.7) II= 94 (42.2) II= 7 (19.4)
IIIN= 57 (23.3) IIIN= 34 (15.2) IIIN= 15 (41.7)
IIIM= 35 (14.3) IIIM= 38 (17.0) IIIM= 11 (30.6)
IV= 6 (1.6) IV= 9 (4.0) IV= 0 (0)
V= 1 (0.4) V= 1 (0.4) V= 0 (0)
Cardiovascular disease No= 195 (79.6) No= 149 (66.8) No= 29 (80.6)
Historya Yes= 50 (20.4) Yes= 74 (33.2) Yes= 7 (19.4)
Cerebrovascular No= 203 (82.9) No= 189 (84.8) No= 26 (72.2)
Accident history Yes= 42 (17.1) Yes= 34 (15.2) Yes= 10 (27.8)
Mean systolic blood pressure (mmHg) 148.9± 19.0 (98.3–217.0) 149.8± 17.5 (98.3–198.7) 146.3± 20.3 (82.3–188)
Mean diastolic blood pressure (mmHg) 78.6± 9.3 (56.3–103.0) 77.2± 9.3 (50.7–104.7) 77.6± 11.1 (50.7–103.7)
Total cholesterol (mmol l− 1) 5.3± 1.1 (2.5–9.2) 5.1± 1.5 (2.8–10.1) 5.4± 1.2 (3.0–7.6)
LDL (mmol l− 1) 3.1± 1.0 (0.8–5.9) 2.9± 1.1 (0.6–7.5) 3.1± 1.3 (0.5–5.5)
HDL (mmol l− 1) 1.5± 0.4 (0.7–2.9) 1.4± 0.4 (0.7–2.8) 1.6± 0.5 (0.9–3.5)
Cholesterol/HDL ratio 3.7± 1.1 (1.7–7.7) 3.7± 1.1 (1.4–7.4) 3.8± 1.3 (1.3–6.1)
Triglycerides (mmol l− 1) 1.5± 0.8 (0.4–4.5) 1.7± 0.8 (0.4–4.3) 1.7± 0.7 (0.6–3.1)
Diabetes history No= 224 (91.4) No= 193 (86.5) No= 34 (94.4)
Yes= 21 (8.6) Yes= 30 (13.5) Yes= 2 (5.6)
HbA1c (%) 5.7± 0.6 (4.4–8.6) 5.8± 0.7 (4.8–9.1) 5.7± 0.5 (4.6–7.2)
Forced expiratory volume (l)b 2.4± 0.7 (0.4–4.2) 2.3± 0.6 (0.8–3.9) 1.9± 0.7 (0.8–3.25)
Hospital anxiety and depression scale score 2.3± 2.0 (0–11) 2.7± 2.2 (0–12) 2.9± 2.2 (0–9)
Alcohol units per weekc 8.1± 11.8 (0–84) 11.9± 13.5 (0–63) 12.4± 23.6 (0–120)
Abbrevations: ANOVA, analysis of variance; HDL, high-density lipoproyein; LDL, low-density lipoprotein; MRI, magnetic resonance imaging. Results for
continuous variables are reported as mean± s.d. (range). Results for categorical variables are reported as n (percentage). There are no statistically signiﬁcant
differences between groups, except for the three following variables: aCardiovascular disease history: χ2(2)= 10.77, P= 0.005; only contrast between subject
that never smoked and ex-smoker is signiﬁcant with Fisher’s exact test (P= 0.002). bForced expiratory volume in 1 s: one-way ANOVA F (2501)= 7.53, P= 0.001;
never versus current and ex versus current smoker contrasts signiﬁcant with post-hoc Tukey’s test. cAlcohol units per week: one-way ANOVA F (2501)= 5.11,
P= 0.006; only never versus ex-smoker contrast signiﬁcant with post-hoc Tukey’s test.
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To assess whether the association between smoking and cortical
thickness varied as a function of the age of starting smoking, Models 2 and
3 were retested after including ‘smoking starting age’ and the ‘smoking
starting age’ by ‘pack-years’ interaction term.
Model 4. To assess whether the potential impact of smoking on cortical
thickness could be reversed, we then examined the association between
pack-years-adjusted cortical thickness and number of years since smoking
the last cigarette. As all subjects were scanned at essentially the same age,
the rationale is that for a given amount of lifetime smoking (that is, pack-
years), if the possible effect of smoking is at least partially reversible, then
those who stopped smoking long ago should have a thicker cortex than
those who stopped smoking more recently or are currently smoking. This





The mean age (mean± s.d.) at MRI was 72.7 ± 0.74 years for those
that never smoked, 72.7 ± 0.76 for ex-smokers and 72.7 ± 0.63 for
current smokers. The mean pack-years value was 26.9 ± 29.15 for
ex-smokers and 46.9 ± 25.07 for current smokers. Table 1 further
describes the mean, range, frequency and variance of basic
demographic and clinical variables, partitioned by smoking
category. Of note, there were no signiﬁcant differences in age at
MRI, gender distribution, SES and IQ at age 11 years between the
three smoking categories (never smoked, ex-smokers and current
smokers), suggesting that the groups were reasonably well
matched at baseline. In fact, the three smoking categories only
differed for cardiovascular disease history (χ2(2) = 10.77, P= 0.005),
forced expiratory volume in 1 s (F (2501) = 7.53, P= 0.001) and
alcohol units per week (F (2501) = 5.11, P= 0.006).
Associations between smoking status and cortical thickness
Controlling for gender and exact age at scanning (Model 1)
showed that current smokers had a generally thinner cortex than
those who had never smoked (Figure 2a). Many of the most
signiﬁcant regions of associations were in prefrontal areas.
Nonetheless, associations were widespread, including most of
the cortex and sparing only some primary motor/sensory and
occipital areas. Using the same model but comparing ex-smokers
with current smokers revealed a similar but less extensive pattern
of thinner cortex for current smokers (Figure 2b). Relatively thinner
cortex was predominantly located in large areas of the medial and
lateral frontal cortex, in addition to some regions of the medial
and lateral temporal and parietal cortices. Comparing ex-smokers
with participants who had never smoked also showed a thinner
cortex for ex-smokers in many areas (Figure 2c). Associations were
less extensive than for the previous two contrasts, but peaks were,
here also, predominantly located in prefrontal areas.
Using the same model as above (Model 1), a highly signiﬁcant
association between smoking status and mean cortical thickness
was observed (F (2, 499) = 14.7, Po0.001; Figure 2d). Follow-up
analyses on this model showed that all pairwise comparisons
between the three smoking categories were signiﬁcant (Bonfer-
roni-corrected threshold of P⩽ 0.017; for details, including Cohen’s
d-values, see Supplementary Table S1).
Dose-dependent association between smoking and cortical
thickness
Controlling for gender and exact age at scanning (Model 2) in
current and ex-smokers (n= 259) showed negative widespread
Figure 2. Cortical thickness contrasts between the three smoking
categories. Areas in orange–yellow shades represent statistically
signiﬁcant group differences at a falsediscovery rate (FDR)= 0.05.
Color bar represents FDR q-values. For each panel, the top left brain
image represents a view from the top, the bottom left image
represents a view from the bottom (the black section is where the
brain stem begins), the middle top image represents the left lateral
view, the middle bottom image represents the left medial view (the
black section is where the hemispheres meet), the top right image
represents the right lateral view and the bottom right image
represents the right medial view. (a) Areas in which those that never
smoked have a thicker cortex than current smokers. (b) Areas in
which ex-smokers have a thicker cortex than current smokers. (c)
Areas in which those that never smoked have a thicker cortex than
ex-smokers. (d) Mean cortical thickness ± 1s.e.m. of current, ex- and
those that never smoked.
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associations between pack-years and cortical thickness (Figure 3a).
Within areas of signiﬁcant associations, partial Pearson correlation
values ranged from − 0.35 to − 0.11 (mean± s.d.; − 0.18 ± 0.04).
Associations had a distribution (Supplementary Table S2) similar to
the one observed in the categorical analyses done above using
Model 1.
Re-examining the dose–response smoking association after
controlling for potential mediating and confounding variables
Figure 3. Associations between the number of pack-years and local cortical thickness (n= 259). Areas in orange–yellow shades represent
statistically signiﬁcant associations at a false discovery rate (FDR)= 0.05. Color bar represents FDR q-values. For a description of what three-
dimensional (3D) perspective each speciﬁc brain image represents, see Figure 2 legend. (a) Association between pack-years and cortical
thickness controlling only for gender and exact age at scanning. A scatterplot of the association between pack-years and mean cortical
thickness within signiﬁcant areas of thinning is also provided (thickness values in mm). (b) Association between pack-years and cortical
thickness controlling for all covariates. A scatterplot of the association between pack-years and mean cortical thickness within signiﬁcant areas
of thinning is also provided (thickness values in mm).
Smoking and cortical thickness
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(Model 3) with an FDR threshold set at 0.05 revealed a strongly
attenuated pattern of signiﬁcant associations. Nonetheless, peaks
were mainly located in prefrontal areas here as well. Within areas
of associations, the partial Pearson correlation values ranged from
− 0.29 to − 0.19 (mean± s.d.; − 0.22 ± 0.02). Using the more lenient
FDR= 0.2 threshold uncovered the original pattern of association
found in Figure 3a, where only gender and exact age at scanning
were used as covariates. Within areas of associations, the partial
Pearson correlation values ranged from − 0.29 to − 0.09 (mean± s.
d.; − 0.13 ± 0.03). Here too, peaks were mainly located in
prefrontal areas.
A signiﬁcant association between pack-years and global mean
cortical thickness was observed when controlling for only gender
and exact age at scanning (Model 2; F (1, 255) = 18.9, Po0.001,
partial Pearson correlation =− 0.26; see Figure 3a) and when also
controlling for all covariates (Model 3; F (1, 238) = 4.5, P= 0.035,
partial Pearson correlation =− 0.14 ;see Figure 3b).
No interactions between starting age and pack-years were
found in any analyses.
Post-hoc explorations revealed that the greatest attenuation in
number of signiﬁcant vertices for the association between
cigarette smoking and cortical thickness was due to the inclusion
of FEV1 and Fazekas score in the model (see Supplementary
Figure S1).
Reversibility of the smoking–cortical thickness association
Controlling for pack-years, gender and exact age at scanning
(Model 4), positive associations were shown between cortical
thickness at age 73 years and number of years since smoking the
last cigarette (Figure 4a and Supplementary Table S3). We shall
name these signiﬁcant regions as areas of ‘recovery,’ yet
acknowledge that although supported, this labeling is not derived
from longitudinal data. Peaks, which had all been shown in the
association with smoking in the above analyses using Models 1
and 2, were mainly located, bilaterally, in the supramarginal gyrus,
the superior temporal gyrus, the anterior and posterior cingulate,
the posterior insular cortex and the fusiform and parahippocampal
gyri. For a plot, within regions of recovery, of years since quitting
against mean cortical thickness adjusted for pack-years, gender
and exact age, see Figure 4a. The rate, within these regions, of
mean cortical thickness recovery adjusted for pack-years, gender
and exact age at scanning was 3.69 μm per year since the last
cigarette (95% conﬁdence interval, 2.03 to 5.35 μm; Po0.001).
Conversely, adjusting for gender and exact age at scanning, but
looking instead at rate of thinning in current smokers (to avoid
confounding this rate by the effect of recovery that is observed in
ex-smokers), revealed, within areas of pack-years-associated
cortical thinning, that mean cortical thickness was 3.21 μm thinner
for every pack-year smoked (95% conﬁdence interval, − 5.82 to
− 0.60 μm; P= 0.017). This suggests that it takes ~ 0.9 years without
smoking, to recover from the possible cortical thinning effect of
each pack-year. On this basis and given that the average pack-
years in this sample’s current and ex-smokers was 29.7, it took
roughly 25 years without smoking for differences in cortical
thickness to no longer be observed between ex-smokers and
those that never smoked. However, heavy ex-smokers remained
with a thinner cortex at age 73 years even after more than 25
years without smoking.
Conclusions regarding the potential reversibility of the possible
impact of smoking on the cortex should mainly be based on
Model 4 results as well as associated Figure 4a. However, to help
visualization, three groups of smokers (current smokers, late
quitters and early quitters) that matched exactly for pack-years
(24.4 pack-years) were created. The median value of time since
quitting (28 years) was used as cutoff to distinguish ‘early’ and
‘late’ quitters. The group with the greatest mean thickness was the
group that never smoked, followed by the early quitters, the late
Figure 4. Associations between the number of years since last
smoked and local cortical thickness (n= 259). Areas in orange–yellow
shades represent statistically signiﬁcant associations at a false
discovery rate (FDR)= 0.05. Color bar represents FDR q-values. For a
description of what three-dimensional (3D) perspective each speciﬁc
brain image represents, see Figure 2 legend. (a) Association between
the number of years since last smoked and cortical thickness
controlling for pack-years, gender and exact age at scanning. A
scatterplot of the association between pack-years and mean cortical
thickness within signiﬁcant areas of recovery is also provided
(thickness values in mm). (b) For visualization purposes, a bar graph
depicting centered mean cortical thickness within areas of recovery
in a sub-sample of early quitters (⩾28 years since quitting), late
quitters (o28 years since quitting) and current smokers precisely
matched for pack-years. The mean pack-years for each of the three
groups is 24.4 pack-years. The mean reported number of cigarettes
smoked per day was 8.9 for current smokers against 16.1 for late
quitters and 31.7 cigarettes for early quitters. The complete
subsample of those that never smoked was used in order to get
the best possible estimate of mean thickness for that group, as it was
not constrained by the requirements of matching for pack-years.
Smoking and cortical thickness
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quitters and the current smokers, respectively (see Figure 4b).
Note that the last three groups have smoked the exact same
amount during their lifetime.
DISCUSSION
This study demonstrates a dose-dependent negative association
between cigarette smoking and cortical thickness that is more
extensive than previously reported.4–7,10–12 Although for each
pack-year smoked, the cortex is only very slightly thinner than in
subjects who never smoked, this rate of smoking-related thinning
is approximately twice that of a previously observed yearly rate of
mean cortical thinning in typical adult populations.29 This being
said, most smokers in this sample smoked much more than one
pack-year and tended to have a cortical thickness compatible with
an even greater rate of thinning. The other key ﬁnding is a positive
association between number of years without smoking and
cortical thickness after accounting for the lifetime ‘dose’ of
smoking; this result supports a reversal, after smoking cessation, of
the potential impact of smoking on the cortex.
Before the current work, the largest study that had looked at
associations between smoking and cortical thickness had a sample
size of 118 subjects11 (that is, almost ﬁve times less than the
current study) with only 76 of these 118 subjects actually used to
examine the effect of smoking. In all likelihood, it is the
combination of the statistical power of the large brain-imaging
sample of the LBC1936 and of the use of the cortical thickness
metric that made it possible to discover such a widespread
negative association between cigarette smoking and cortical
tissue. Such a diffuse association is in keeping with reported
negative associations between smoking and cognitive ability
shown in the LBC1936 (ref. 2) and in other samples.30 Associations
between pack-years and cortical thinning were greatest in
statistical signiﬁcance in the medial and lateral prefrontal areas,
posterior cingulate gyrus, precuneus, medial and lateral temporal
areas, and the angular gyrus, regions that are all part of the default
mode network.31 Given the known breakdown in functional
connectivity of the default mode network in Alzheimer’s disease,
these observations accord with reported associations between
smoking and increased risk of Alzheimer’s disease.3
Findings here suggest that cortical recovery could take as little
as a few weeks to more than a theoretical 140 years (mean of ~ 25
years for the LBC1936), depending on the amount smoked over
one’s lifetime. Although the mechanisms behind the observed
potential recovery of cortical thickness after smoking cessation are
unknown, plausible and potentially complementary models of the
dynamics of recovery can nonetheless be proposed. Although, in
adulthood, the cortex tends to thin slowly with age,29 ﬁndings
here suggest that cigarette smoking might accelerate this process.
Within this framework, one possibility could be that after smoking
cessation, the rate of cortical thinning decreases to such an extent
that it becomes slower than that seen in normal aging non-
smoking adults, leading to an eventual ‘catching up’ of ex-
smokers. An alternative, of course, is that smoking cessation is
associated with some degree of cortical thickening. Both proposed
mechanisms are compatible with a homeostatic set point view of
cortical thickness where the cortex would tend to settle towards
its ‘normal age’ set point after smoking cessation. Having said this,
the imputed reversal was not observed in all regions where there
was a negative association between smoking and cortical
thickness. This is not surprising given that smoking is likely
associated to some degree of microvascular-related lesions with
irreversible secondary cortical loss.32
Controlling for all covariates (Model 3) showed a weaker but
nonetheless persistent negative association between smoking and
cortical thickness, which is compatible with part of the association
being due to the direct neurotoxic effects of cigarette smoking.
Although to establish this completely would require more
mechanistic evidence, a direct neurotoxic effect of cigarette
smoking is compatible with reported associations in rodents
between prenatal exposure to nicotine and reduced cingulate
cortex volume, dopamine turnover, brain size, dendritic morphol-
ogy and spine density.33,34
Conversely, the attenuation of the association between smok-
ing and cortical thickness, when controlling for all covariates
suggests that some of the possible impact of cigarette smoking on
the cortex is indirect. The ﬁve covariates with the greatest impact
all had an attenuating effect on results. They include FEV1, Fazekas
score, IQ, HADS score and SES (for details, see Supplementary
Figure S1). Of all the covariates, FEV1 had the strongest impact on
results, a ﬁnding compatible with links between chronic
obstructive pulmonary disease, chronic hypoxemia and cognitive
impairment.35 Fazekas score had the second strongest attenuating
inﬂuence on results, suggesting that subclinical vascular disease
secondary to cigarette smoking might also have a role in the
association between smoking and cortical changes. However, as
noted in the methods, given known strong links between
cigarette smoking and FEV1 (ref. 28) as well as with cerebrovas-
cular disease,1 it is necessary to acknowledge the possibility that
covarying for FEV1 and Fazekas score might substantially control
for the amount of smoking and hence overcorrect for the possible
impact of smoking on the cortex.
A limitation of this study is its observational nature. Further, one
needs to be cognizant of the possibility that reverse causation
may account for a certain amount of the association between
smoking and cortical thinning. For instance, we show that IQ at 11
years accounts for a certain degree of association between
smoking and cortical thickness (Supplementary Figure S1). This
supports the view that a certain proportion of the cortical
thickness/smoking association is not due to direct or indirect
effects of cigarette smoking on the cortex given that those with a
lower IQ have both a thinner cortex16,36 and a higher propensity
to smoke.2 Similarly, structural differences in cortical areas related
to impulse control (for example, the orbitofrontal cortex) might
predispose to smoking and therefore predate it rather than follow
from it.37 This being said, the identiﬁed dose-dependent associa-
tions in diffuse brain areas (including regions without evidence for
a role in impulse control) and the apparent reversal of the effect of
smoking on the cortex provide evidence that the differences in
thickness do not mostly predate the onset of smoking. In addition,
although the sample of current smokers (n= 36) is greater than
most studies looking at the impact of smoking on the brain, it
remains a relatively small sample. Another limitation is the recalled
nature of the smoking history data; however, recall errors would
tend to add noise to the data and reduce the degree of
association between smoking and cortical thickness. On such a
basis, the degree of association between smoking and cortical
thickness is likely to be even stronger than observed here. This
being said, none of these caveats have an impact on the
conclusions of the current work or decrease many of its strengths,
which include the following: blinded quality control of imaging
data; having all participants scanned at the same age, thereby
minimizing potential confounding complex age effects; having
the largest sample to date examining smoking-related cortical
thickness associations; and availability of cognitive ability before
smoking, which provided the rare opportunity to rule out a
potential important confounder to smoking/brain structure
associations.
Smokers need to be informed that cigarettes are associated
with accelerated cortical thinning, a biomarker of cognitive aging.
Importantly, cortical thinning can persist for many years after
smoking cessation. The potential to at least partially recover from
smoking-related thinning might serve as a strong motivational
argument to encourage smoking cessation.
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